bioMérieux S.A. (BMXMF)
USD 103.09
(0.0%)
USD 103.09
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 355.4 Million EUR | 11.62% |
| 2022 | 318.4 Million EUR | -12.24% |
| 2021 | 362.8 Million EUR | 2.95% |
| 2020 | 352.4 Million EUR | 129.28% |
| 2019 | 153.7 Million EUR | -65.6% |
| 2018 | 446.8 Million EUR | 14.24% |
| 2017 | 391.1 Million EUR | 7.03% |
| 2016 | 365.4 Million EUR | 18.29% |
| 2015 | 308.9 Million EUR | 1.05% |
| 2014 | 305.7 Million EUR | 0.36% |
| 2013 | 304.6 Million EUR | 3008.16% |
| 2012 | 9.8 Million EUR | -22.22% |
| 2011 | 12.6 Million EUR | 68.0% |
| 2010 | 7.5 Million EUR | -10.71% |
| 2009 | 8.4 Million EUR | -89.24% |
| 2008 | 78.1 Million EUR | 329.12% |
| 2007 | 18.2 Million EUR | 5.2% |
| 2006 | 17.3 Million EUR | 2.37% |
| 2005 | 16.9 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 237.2 Million EUR | 1.28% |
| 2023 Q2 | 330.1 Million EUR | 3.67% |
| 2023 FY | 355.4 Million EUR | 11.62% |
| 2023 Q4 | 355.4 Million EUR | 7.66% |
| 2022 Q4 | 318.4 Million EUR | -12.93% |
| 2022 FY | 318.4 Million EUR | -12.24% |
| 2022 Q2 | 365.7 Million EUR | 0.8% |
| 2021 Q4 | 362.8 Million EUR | 0.36% |
| 2021 FY | 362.8 Million EUR | 2.95% |
| 2021 Q2 | 361.5 Million EUR | 2.58% |
| 2020 Q2 | 338.1 Million EUR | 119.97% |
| 2020 Q4 | 352.4 Million EUR | 4.23% |
| 2020 FY | 352.4 Million EUR | 129.28% |
| 2019 Q4 | 153.7 Million EUR | -70.45% |
| 2019 FY | 153.7 Million EUR | -65.6% |
| 2019 Q2 | 520.2 Million EUR | 16.43% |
| 2018 Q4 | 446.8 Million EUR | 12.09% |
| 2018 FY | 446.8 Million EUR | 14.24% |
| 2018 Q2 | 398.6 Million EUR | 1.92% |
| 2017 Q2 | 376.8 Million EUR | 3.12% |
| 2017 FY | 391.1 Million EUR | 7.03% |
| 2017 Q4 | 391.1 Million EUR | 3.8% |
| 2016 FY | 365.4 Million EUR | 18.29% |
| 2016 Q2 | 312.4 Million EUR | 1.13% |
| 2016 Q4 | 365.4 Million EUR | 16.97% |
| 2015 FY | 308.9 Million EUR | 1.05% |
| 2015 Q4 | 308.9 Million EUR | 1.18% |
| 2015 Q2 | 305.3 Million EUR | -0.13% |
| 2014 Q2 | 305.6 Million EUR | 0.33% |
| 2014 Q4 | 305.7 Million EUR | 0.03% |
| 2014 FY | 305.7 Million EUR | 0.36% |
| 2013 Q2 | 7.6 Million EUR | -22.45% |
| 2013 Q4 | 304.6 Million EUR | 3907.89% |
| 2013 FY | 304.6 Million EUR | 3008.16% |
| 2012 Q2 | 13.5 Million EUR | 7.14% |
| 2012 FY | 9.8 Million EUR | -22.22% |
| 2012 Q4 | 9.8 Million EUR | -27.41% |
| 2011 Q2 | 9.3 Million EUR | 24.0% |
| 2011 FY | 12.6 Million EUR | 68.0% |
| 2011 Q4 | 12.6 Million EUR | 35.48% |
| 2010 Q4 | 7.5 Million EUR | 1.35% |
| 2010 FY | 7.5 Million EUR | -10.71% |
| 2010 Q2 | 7.4 Million EUR | -11.9% |
| 2009 FY | 8.4 Million EUR | -89.24% |
| 2009 Q4 | 8.4 Million EUR | 0.0% |
| 2008 FY | 78.1 Million EUR | 329.12% |
| 2007 FY | 18.2 Million EUR | 5.2% |
| 2006 FY | 17.3 Million EUR | 2.37% |
| 2005 FY | 16.9 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -5923233.333% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -27290.841% |
| Biocept, Inc. | 10.37 Million USD | -3325.542% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | -592.68% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | -480.479% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -64952.972% |
| iMD Companies, Inc. | 1.1 Million USD | -32101.771% |
| IDenta Corp. | 428.17 Thousand USD | -82903.251% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -8276.149% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -127741.727% |
| NovelStem International Corp. | 3.32 Million USD | -10590.011% |
| Optigenex Inc. | 4.42 Million USD | -7927.888% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -21690.313% |
| Response Genetics, Inc | 4.91 Million USD | -7126.515% |
| Rennova Health, Inc. | 359.19 Thousand USD | -98844.022% |
| RushNet, Inc. | 4.25 Million USD | -8257.655% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -142602.269% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -44411.742% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -61560.496% |
| Todos Medical Ltd. | 33 Million USD | -976.937% |